FDA clears Starplex' on-site drugs test:
This article was originally published in Clinica
Executive Summary
Starplex Scientific has received US FDA 510(k) clearance for its on-site point-of-care urine test that can detect drugs of abuse within five minutes. Startox is a self-contained sample collection and analysis device designed to identify cocaine, opiates, THC, PCP, and amphetamines in urine simultaneously. It incorporates a sample cup designed by Etobicoke, Ontario-based Starplex, and patented membrane strips developed by American Bio Medica.
You may also be interested in...
US FDA Drugs Center Ready To Break Down Silos On Regulatory Innovation
CDER Director Cavazzoni is promising to increase coordination and collaboration to accelerate broader adoption of innovative clinical trial designs and other approaches to speed drug development. A new "Quantitative Medicine Center of Excellence" illustrates the approach.
New OSP Director To Guide CDER-Wide IT Upgrades; System Enhancements Speed ANDA Assessments
Generic Drug Structured Assessment for Bioequivalence launched in 2023 and has been used in 40 ANDA reviews so far.
New EU Approvals
The Pink Sheet's list of EU centralized approvals of new active substances has been updated to add two new products, including Ryzneuta, Evive Biotechnology's treatment for chemotherapy-induced neutropenia.